CN115232158B - Fluorescent probe for detecting polarity of targeted lipid droplets and preparation method and application thereof - Google Patents
Fluorescent probe for detecting polarity of targeted lipid droplets and preparation method and application thereof Download PDFInfo
- Publication number
- CN115232158B CN115232158B CN202210527831.9A CN202210527831A CN115232158B CN 115232158 B CN115232158 B CN 115232158B CN 202210527831 A CN202210527831 A CN 202210527831A CN 115232158 B CN115232158 B CN 115232158B
- Authority
- CN
- China
- Prior art keywords
- cells
- polarity
- fluorescent probe
- probe
- fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 41
- 150000002632 lipids Chemical class 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 24
- 238000003384 imaging method Methods 0.000 abstract description 10
- 230000008685 targeting Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 3
- 230000003013 cytotoxicity Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 10
- 241000252212 Danio rerio Species 0.000 description 9
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- XFVZSRRZZNLWBW-UHFFFAOYSA-N 4-(Diethylamino)salicylaldehyde Chemical compound CCN(CC)C1=CC=C(C=O)C(O)=C1 XFVZSRRZZNLWBW-UHFFFAOYSA-N 0.000 description 3
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- NSYSSMYQPLSPOD-UHFFFAOYSA-N triacetate lactone Chemical compound CC1=CC(O)=CC(=O)O1 NSYSSMYQPLSPOD-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000033077 cellular process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100033072 DNA replication ATP-dependent helicase DNA2 Human genes 0.000 description 1
- 101000927313 Homo sapiens DNA replication ATP-dependent helicase DNA2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000019298 Lipocalin Human genes 0.000 description 1
- 108050006654 Lipocalin Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 230000008045 co-localization Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- -1 dimethylaminophenyl Chemical group 0.000 description 1
- VDQVEACBQKUUSU-UHFFFAOYSA-M disodium;sulfanide Chemical compound [Na+].[Na+].[SH-] VDQVEACBQKUUSU-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007762 localization of cell Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Abstract
The invention provides a fluorescent probe for detecting polarity of a targeted lipid drop, which is called SG-LDs for short, and has a chemical structural formula of; The fluorescent probe has the advantages of simple synthesis process, capability of targeting lipid drops, sensitivity to polarity, low cytotoxicity, capability of imaging in cells and tissues, high light stability and wide application range, and is a novel near infrared probe.
Description
Technical Field
The invention belongs to the technical field of analytical chemistry, and particularly relates to a fluorescent probe for detecting polarity of a targeted lipid droplet and application thereof.
Background
In biology, the polarity of the cellular microenvironment is one of the key factors affecting various cellular processes. Some cellular processes, which are related to spatial arrangement and protein composition, have an inseparable relationship to polarity, such as cell differentiation, membrane growth of individual subcellular organelles, and transmembrane transport. Importantly, polarity changes in real time as the state of the cell changes, and abnormalities in polarity often lead to the onset of diseases such as: diabetes, depression, and the like. Therefore, detection of changes in polarity of biological microenvironments is of critical importance in studying the occurrence and diagnosis of these diseases. Although the methods for detecting the polarity of biological microenvironments have been diverse and rapidly developed in recent years, precise and comprehensive techniques remain lacking.
Lipid Droplets (LDs) are lipid subcellular organelles essential for cell metabolism and energy storage, which are encapsulated in phospholipid layers, ubiquitous in various cell types, and involved in various physiological processes. Lipid droplets have long been ignored as a lipid organelle, and in fact are closely related to many physiological activities. The occurrence of some metabolic diseases is not separated from the change of the number and polarity of lipid droplets, such as fatty liver, liver injury and hepatitis. In the early stage of liver diseases, the metabolism of lipid is obviously up-regulated, LDs can accumulate in cells except fat cells, so that the polarity of lipid droplets of pathological cells is obviously lower than that of normal cells, but the number of lipid droplets is greatly increased. Therefore, detecting whether the number and polarity of lipid droplets are abnormal can distinguish normal cells from diseased cells, and finding a method capable of targeting and monitoring lipid droplets in real time is particularly important for early prediction of cytopathy and diseases.
The fluorescent probe has high sensitivity, can realize real-time monitoring while targeting and positioning, attracts high attention of researchers, and is widely applied to detection of small molecules or microenvironments in living systems. Whereas near infrared fluorescent probes can penetrate living tissue and can inhibit photodamage to cells and tissues, some diseases can be visualized for in vivo detection. Currently Bodipy493/503 green and Nile Red are the most commercially used LDs fluorescent dyes. However, the lack of specificity of Bodipy493/503 green and Nile Red limits the use of these two probes at the cellular level and does not recognize tissue microstructure.
Disclosure of Invention
Aiming at the problem of poor specificity of lipid drop probes in the prior art, the invention provides a fluorescent probe for detecting polarity by targeting lipid drops, which is sensitive to polarity and low in toxicity, can be imaged in cells, tissues and organisms, and has wide application prospect.
Another object of the present invention is to provide an application of the above fluorescent probe in detecting the polarity of a solution, a cell or a tissue.
In order to achieve the above purpose, the present invention adopts the following technical scheme.
A fluorescent probe for detecting polarity of a targeted lipid drop is called SG-LDs for short, and the chemical structural formula of the fluorescent probe is shown as formula (I):
formula (I).
The preparation method of the fluorescent probe comprises the following steps:
(1) 4- (diethylamino) -salicylaldehyde and 4-hydroxy-6-methyl-pyrone react in ethanol under the catalysis of piperidine in a protective atmosphere, the solid-liquid separation of the reaction mixture is carried out, and the solid product is SG-1:
;
(2) SG-1 and boron trifluoride-diethyl etherate react in methylene dichloride in protective atmosphere, the solid-liquid separation of reaction mixture, solid purification get SG-2:
;
(3) SG-2 and 4-dimethylamino benzaldehyde react in toluene under the catalysis of piperidine, and after the reaction is finished, a blue compound is obtained through separation and purification, namely, the fluorescent probe is obtained:
。
In the step (1), the molar ratio of the 4- (diethylamino) -salicylaldehyde to the 4-hydroxy-6-methyl-pyrone is 4:3.
In step (1), the reaction temperature was 80 ℃.
In the step (2), the molar ratio of SG-1 to boron trifluoride-diethyl etherate is 1:1.
In the step (2), the reaction temperature is 0-4 ℃.
In step (2), the purification step is to recrystallize the solid from chloroform.
In the step (3), the molar ratio of the SG-2 to the 4-dimethylaminobenzaldehyde is 1.5:1
In the step (3), the reaction temperature is 20-30 ℃.
In the step (3), the reaction liquid is spin-dried, dissolved by methylene dichloride, washed by water, the organic phase is taken after layering, concentrated and chromatographed by a silica gel column, methylene dichloride and petroleum ether with the volume ratio of 2:1 are taken as eluent, and the eluent is distilled under reduced pressure.
Use of a fluorescent probe as described above for detecting the polarity of a solution, lipid droplets or polarity in a cell, tissue or organism.
The mechanism of the invention is as follows:
In the probe molecule, dimethylaminophenyl is an electron-donating group, and can form a strong intramolecular electron-pushing system in the molecule, so that an excited state Intramolecular Charge Transfer (ICT) process is caused, and the probe molecule is fluorescent. In the case of increasing polarity, the excited state energy of the probe is rapidly dissipated in the solvent through dipole-dipole interaction, so that the probe has a longer wavelength and lower fluorescence intensity in a high-polarity environment, and the blue shift phenomenon of the emitted light wavelength of the probe molecule occurs and the fluorescence intensity is enhanced with the decrease of the polarity of the surrounding environment.
The invention has the following advantages:
therefore, a new polarity sensitive fluorescent probe SG-LDs of the near infrared targeting lipid drop is designed according to the targeting positioning capability of the fluorescent probe. The probe is subjected to optical analysis by spectral test, and the polarities of different solvents in a microenvironment can be accurately analyzed, so that the probe is proved to be sensitive to the polarities; cytotoxicity test proves that the probe has weak toxicity and can be used in clinical medicine; cell and tissue imaging (mice normal liver, fatty liver, injured liver and hepatitis mice) tests, the probe can well target lipid droplets and observe the polarity change, thereby distinguishing diseased cells from normal cells.
Compared with other positioning lipid drop probes, the probe is a novel near infrared probe, has strong light stability and wide application range.
Drawings
FIG. 1 is a hydrogen spectrum of a fluorescent probe;
FIG. 2 is a carbon spectrum of a fluorescent probe;
FIG. 3 is a mass spectrum of a fluorescent probe;
FIG. 4 is a cytotoxicity experiment of fluorescent probes in different cells;
FIG. 5 is a reaction of a fluorescent probe to solutions of different polarities;
FIG. 6 is a graph showing selectivity of fluorescent probes for different substances;
FIG. 7 is an image of fluorescent probes in cells of different polarity;
FIG. 8 is an image of lipid droplets in a fluorescent probe and bodipy located in different cells;
FIG. 9 is an imaging application of fluorescent probes in zebra fish;
FIG. 10 is a fluorescent probe for use in mouse liver imaging.
Detailed Description
The present invention will be further described with reference to examples and drawings, but the present invention is not limited to the examples.
Example 1 Synthesis of fluorescent probes
(1) Dissolving 4- (diethylamino) -salicylaldehyde (3.829 g,30.3 mmol g,40 mmol) and 4-hydroxy-6-methyl-pyrone (5 g,40 mmol) in 50mL ethanol under nitrogen protection, stirring and heating to 80deg.C, adding a certain amount of piperidine into the system during heating, refluxing for 4h, and filtering when orange crystal is precipitated in the system to obtain solid product SG-1(2.3g,30%),1 H NMR (500 MHz, CDCl3-d) δ 8.52 (s, 1H), 7.40 (dd, J = 8.9 Hz, 1H), 6.98 (s, 1H), 6.66 (dd, J1= 9.0 Hz, J2 = 2.3 Hz, 1H), 6.51 (d, J = 2.3 Hz, 1H), 3.48 (q, J = 7.2 Hz, 4H), 2.22 (s, 3H), 1.25 (t, J = 7.1 Hz, 6H):
;
(2) Under the protection of nitrogen, 10mL of anhydrous dichloromethane is added dropwise to SG-1 (600 mg,2 mmol) to dissolve the water, 8g of boron trifluoride diethyl etherate is added into the system under the ice bath condition, white solid is separated out along with the reaction, the reaction is carried out for 8 hours, suction filtration is carried out, the crude product is obtained, and then chloroform is used for recrystallization, thus obtaining solid SG-2(599mg,86%),1 H NMR (500 MHz, CDCl3-d) δ 8.79 (s, 1H), 7.45 (d, J = 10 Hz, 1H), 7.44 (s, 1H), 6.70 (dd, J1 = 10 Hz, J2 = 2.3 Hz, 1H), 6.47 (d, J = 2.3 Hz, 1H), 3.51 (q, J = 7.2 Hz, 4H), 2.39 (s, 3H), 1.28 (t, J = 7.2 Hz, 6H):
;
(3) SG-2 (300 mg,0.62 mmol) was dissolved in 10mL toluene, a catalytic amount of piperidine was added to the system, after stirring at room temperature for a period of time, 4-dimethylaminobenzaldehyde (300 mg,2 mmol) was added, the reaction system became purplish red over time, the mixture was dried after 24h of reaction, dissolved in methylene chloride, washed with water, the organic phase was concentrated after separation, and then chromatographed on a silica gel column with 2:1 volume ratio of methylene chloride and petroleum ether as eluent, the eluent was distilled under reduced pressure to give a blue compound, i.e., a fluorescent probe (100 mg, yield 33%):
。
Its 1 H NMR spectrum is shown in figure 1:1 H NMR (500 MHz, DMSO-d6) δ 8.77 (s, 1H), 7.91 (d, J = 15.2 Hz, 1H), 7.81 (d, J = 9.2 Hz, 1H), 7.5 (d, J = 9.5 Hz, 2H), 7.39 (s, 1H), 6.98 (d, J = 15.2 Hz, 1H), 6.88 (dd, J1= 9.2 Hz, J2= 2.4 Hz, 1H), 6.78 (d, J = 9.05 Hz, 2H), 6.66 (d, J = 2.1 Hz, 1H), 3.56 (q, J = 7.0 Hz, 4H), 3.08 (s, 6H), 1.18 (t, J = 7.1 Hz, 6H);
Its 13 C NMR spectrum is shown in figure 2:13 C NMR (125 MHz, DMSO- d6) δ 179.17, 172.68, 159.11, 158.69, 154.64, 153.63, 148.16, 147.74, 133.66, 132.95, 122.24, 115.34, 112.52, 111.55, 109.41, 108.29, 100.13, 96.48, 45.27, 12.93;
The mass spectrum is shown in figure 3:HR-MS (ESI) calcd. for C26H28BF2N2O4 + [M+H]+ m/z 481.2219, found 481.2214;
Fluorescence quantum yield of this probe in different solvents table 1 shows:
TABLE 1 Quantum yield of fluorescent probes
Epsilon-molar absorption coefficient; lambda a -maximum absorption wavelength; lambda b -maximum emission wavelength; phi Fl -fluorescence quantum yield.
Example 2 response of fluorescent probes to solutions of different polarity
3ML of a fluorescent probe stock solution having a concentration of 1mM was prepared for use. Preparing probe concentration of 10 mu M, respectively interacting with PBS buffer solution (10 mmol, pH=7.4) and mixed solution (0%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99% and 100%) of 1, 4-dioxane, setting excitation wavelength of 560nm, detecting fluorescence with detection wavelength of 600-850nm, calculating fluorescence intensity in each system, and establishing a curve related to the proportion of fluorescence intensity to polarity, wherein the result is shown in FIG. 4: as the polarity is reduced, the fluorescence intensity of the reaction system is gradually increased.
Example 3 selectivity of fluorescent probes for different active Agents
The probe concentration was 10. Mu.M, and different positive ions, negative ions and amino acids (:Cys、GSH、Hcy、F-、SO4 2-、Cu2+、ClO-、Ca2+、H2O2、I-、Mg2+、Mn2+、Na2S、Zn2+、 methionine, t-butyl hydroperoxide, arginine, lysine, valine, glycerol, DNA1 (TGAGGTAGTAGGTTGTATAGTT), DNA2 (AACTATACAACCTACTACCTCAGAGTCAGTCATATCTAT) and bovine serum albumin, respectively) were added to give a final concentration of 10mM. Fluorescence detection was performed with excitation wavelength of 560nm and detection wavelength of 580nm to 750nm, and the results are shown in FIG. 5: under the condition of adding different active substances, the fluorescence signal intensity of the SG-LDs is almost unchanged. This indicates that SG-LDs respond negligible to these active species relative to the sensitivity of the probe pair to polarity.
Example 4 toxicity of fluorescent probes to cells
Cytotoxicity experiments were performed on four cells (Hela, HL7702,4T1 and 3T 3): culture media containing different concentrations of probes (1, 2, 5, 10, 20, 30, 40. Mu.M) were added to 96-well plates containing cells for 24 hours of incubation, followed by examination of the viability of the cells. As can be seen from fig. 6, the survival rate of cells is as high as 90% at all concentrations, and regrowth occurs even at lower concentrations.
Application example 1 imaging of fluorescent probes in living cells of different polarities
Four cells (4T 1,3T3, hela, HL7702) were inoculated into 35mm glass-bottomed cell culture dishes, cultured in a carbon dioxide incubator (temperature 37 ℃,5% CO 2), incubated for 30min with 10. Mu.L SG-LDs after the cells had adhered to the wall, washed 3 times with PBS buffer after the end of the culture, and fluorescent photographs of the four cells were taken with a fluorescence microscope, respectively, with lambda ex =580 nm, and the collection band at 610nm-750nm, as shown in FIG. 7: the first column: a bright field; the second column: a red channel; third column: a superimposed field; a first row: HL7702; a second row: hela; third row: 3T3; fourth row: 4T1. The fluorescent probe was found to emit intense fluorescence, indicating that the fluorescent probe was able to distinguish normal cells from cancer cells.
Application example 2 localization of fluorescent probes to lipid droplets in different cells
Cancer cells at a density of 3×10 5/mL were inoculated into 35mm glass-bottomed cell culture dishes and two groups of cells were cultured in a carbon dioxide incubator (37 ℃,5% co 2), one of which was incubated 24 h with 10 mmol oleic acid. After cell attachment, experimental group culture was performed by adding 200nM of lipocalin dye bodipy to cells, incubating for 20min, washing the cells 3 times with PBS buffer, then adding 10. Mu.M probe SG-LDs to a cell culture dish, incubating for 30min in a cell incubator, washing the cells 3 times with PBS buffer, and taking fluorescence photographs of the cells with a fluorescence microscope, respectively, the results are shown in FIG. 8, wherein: a) Co-localization imaging of HeLa cells; b) Co-localized imaging of 3T3 cells; c) Co-localized imaging of 4T1 cells; in each group, 1 is the red channel of SG-LDs; 2 is the green channel of bodipy; 3 is a bright field channel; 4 is the superposition of the three figures; 5 is the intensity distribution of SG-LDs in the red channel and bodipy in the green channel. Green channel: lambda ex =580 nm, collection band is 610nm-750nm, red channel: lambda ex =488 nm, the collection band is 500nm-550nm. The localization coefficients of HeLa cells, 3T3 cells and 4T1 cells are 94.69%, 94.02% and 90.64%, respectively, and the cell localization Coefficient Pearson's Coefficient in three cells is more than 90%, which indicates that the probe can well localize lipid droplets.
Application example 3 imaging application of fluorescent probe in zebra fish
Putting a group of zebra fish into a culture solution containing 1mM oleic acid in advance for incubation for 24 hours, and increasing the number of LDs in the zebra fish; the other group was fed normally. SG-LDs (10. Mu.M) were then incubated with zebra fish for 20min, and fluorescence photographs of the zebra fish cultured under these two groups of conditions were taken with a fluorescence microscope, respectively, and the results are shown in FIG. 9: the first column: a bright field; the second column: a red channel; third column: a superimposed field; a first row: zebra fish with probes only; a second row: zebra fish with probe and oleic acid. Zebra fish added with oleic acid was found to emit a distinct fluorescent signal.
Application example 4 imaging application of fluorescent probe in mouse liver cells
The same-age Kunming mice (female mice) are divided into two groups, one group is fed with high-fat feed for three days, a fatty liver model is built, and the other group is fed with common feed for three days, so that a blank control experiment is realized. The livers in mice were taken out and immersed in 10. Mu.M SG-LDs solution for 6 hours, and then fluorescence imaging was performed at an excitation wavelength of 600nm and an emission wavelength of 660nm, as shown in FIG. 10: the fluorescence intensity of the disease liver model (2-3) is obviously much stronger than that of the common liver model (1). The experimental result shows that SG-LDs has application potential in fatty liver diagnosis.
Claims (1)
1. Use of a fluorescent probe according to formula (I) for the preparation of a reagent for detecting the polarity of a solution, lipid droplets or polarity in cells, tissues or organisms
Formula (I).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210527831.9A CN115232158B (en) | 2022-05-16 | Fluorescent probe for detecting polarity of targeted lipid droplets and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210527831.9A CN115232158B (en) | 2022-05-16 | Fluorescent probe for detecting polarity of targeted lipid droplets and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115232158A CN115232158A (en) | 2022-10-25 |
CN115232158B true CN115232158B (en) | 2024-07-09 |
Family
ID=
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110143977A (en) * | 2019-06-12 | 2019-08-20 | 青岛科技大学 | A kind of miscellaneous boron difluoride complex compound fluorochrome of cumarin and its application |
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110143977A (en) * | 2019-06-12 | 2019-08-20 | 青岛科技大学 | A kind of miscellaneous boron difluoride complex compound fluorochrome of cumarin and its application |
Non-Patent Citations (2)
Title |
---|
"An ultrasensitive lipid droplet-targeted NIR emission fluorescent probe for polarity detection and its application in liver disease diagnosis";Yonghe Tang等;《J. Mater. Chem. B》;20220809;第10卷;第6974–6982页 * |
Tianyi Cheng等."Michael Addition/S,N-Intramolecular Rearrangement Sequence Enables Selective Fluorescence Detection of Cysteine and Homocysteine".《Anal. Chem.》.2019,第91卷第10894-10900页. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111303102A (en) | Nitroreductase responsive hypoxic probe compound and preparation and application thereof | |
CN104949946B (en) | A kind of application of fluorescence probe in hydrogen peroxide molecule detection | |
CN109776564A (en) | The ferrous ion fluorescence probe and its synthetic method of a kind of xanthene structure and application | |
CN109180716B (en) | Multi-signal ratio type distinguishing detection H2O2And H2Design, synthesis and application of fluorescent probe of S | |
CN110643355A (en) | Fluorescent probe for detecting polarity of endoplasmic reticulum as well as preparation method and application thereof | |
CN109970644A (en) | Polar two-photon fluorescence probe of a kind of detection lysosome and its preparation method and application | |
CN111778014A (en) | Beta-galactosidase near-infrared fluorescent probe and preparation method and application thereof | |
CN114763353A (en) | Imidazopyridine mother nucleus-based fluorescence detection reagent and detection technology for signal molecule H2S by using same | |
CN115232158B (en) | Fluorescent probe for detecting polarity of targeted lipid droplets and preparation method and application thereof | |
CN114874188B (en) | Lipid-droplet fluorescent probe containing carbazole-pyridine formylhydrazine group and preparation method and application thereof | |
CN111533730A (en) | Washing-free cell membrane targeted fluorescent probe and preparation method and application thereof | |
CN113004258A (en) | Preparation method and application of hydrogen sulfide ratio type fluorescent molecular probe based on ESIPT effect | |
CN108299485B (en) | Fluorescent probe for detecting hydrogen peroxide in living cells and preparation method and application thereof | |
CN110776458A (en) | Fluorescent probe for detecting mitochondrial membrane potential and preparation method and application thereof | |
CN109913206A (en) | A kind of RNA fluorescence probe and its preparation method and application | |
CN111635385B (en) | Mitochondrion-targeted two-photon excitation near-infrared emission hydrogen sulfide fluorescent probe and preparation method and application thereof | |
CN110229203B (en) | Hexosamine fluorescent probe and preparation method and application thereof | |
CN115232158A (en) | Fluorescent probe for detecting polarity by targeting lipid droplets and preparation method and application thereof | |
CN113683604A (en) | Ratio type near-infrared fluorescent probe for detecting sulfur dioxide derivatives in crop mitochondria and preparation method and application thereof | |
CN113773292B (en) | Washing-free AIEgen fluorescent probe targeting lipid droplets and preparation method and application thereof | |
CN114736223B (en) | Preparation of near infrared fluorescence detection reagent and in-vitro diagnosis application thereof | |
CN114539268B (en) | Cardipy dye-based lysosome targeted fluorescent probe and preparation method and application thereof | |
CN113004310B (en) | Preparation method and application of hydrogen peroxide ratio type fluorescent molecular probe based on DCPO parent nucleus | |
CN114507204B (en) | Golgi apparatus targeted superoxide anion fluorescent probe, preparation method and application thereof | |
CN115043893B (en) | Liver cell targeted hypochlorous acid near infrared fluorescent probe and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |